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Abstract
Background
Sex-related differences as well as the adverse effect of pregnancy on aortic disease out-
come are well-established phenomena in humans with Marfan syndrome (MFS). The under-
lying mechanisms of these observations are largely unknown.
Objectives
In an initial (pilot) step we aimed to confirm the differences between male and female MFS
patients as well as between females with and without previous pregnancy. We then sought
to evaluate whether these findings are recapitulated in a pre-clinical model and performed
in-depth cardiovascular phenotyping of mutant male and both nulliparous and multiparous
female Marfan mice. The effect of 17β-estradiol on fibrillin-1 protein synthesis was com-
pared in vitro using human aortic smooth muscle cells and fibroblasts.
Results
Our small retrospective study of aortic dimensions in a cohort of 10 men and 20 women with
MFS (10 pregnant and 10 non-pregnant) confirmed that aortic root growth was significantly
increased in the pregnant group compared to the non-pregnant group (0.64mm/year vs.
0.12mm/year, p = 0.018). Male MFS patients had significantly larger aortic root diameters
compared to the non-pregnant and pregnant females at baseline and follow-up (p = 0.002
and p = 0.007, respectively), but no significant increase in aortic root growth was observed
compared to the females after follow-up (p = 0.559 and p = 0.352). In the GT-8/+ MFS
mouse model, multiparous female Marfan mice showed increased aortic diameters when
compared to nulliparous females. Aortic dilatation in multiparous females was comparable
to Marfan male mice. Moreover, increased aortic diameters were associated with more
severe fragmentation of the elastic lamellae. In addition, 17β-estradiol was found to promote
fibrillin-1 production by human aortic smooth muscle cells.
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Conclusions
Pregnancy-related changes influence aortic disease severity in otherwise protected female
MFS mice and patients. There may be a role for estrogen in the female sex protective effect.
Introduction
Marfan syndrome (MFS, OMIM #154700) is a heritable connective tissue disorder caused by
mutations in the fibrillin-1 (FBN1) gene (OMIM 134797) [1], which encodes a major compo-
nent of extracellular microfibrils [2, 3]. MFS is a pleiotropic disorder affecting multiple
organ systems, including the skeletal, ocular, and cardiovascular system. Cardiovascular
manifestations in Marfan patients include thoracic aortic aneurysms and dissections
(TAAD) most typically at the level of the sinuses of Valsalva, mitral valve prolapse and sub-
clinical cardiomyopathy and arrhythmias [4–8]. Drivers of progressive aortic dilatation are
largely unknown.
Previously, it was shown that sex impacts aortic disease in MFS. One study investigating
965 probands with pathogenic FBN1 mutations (median age: 22 years (11–34), 53% males)
found that men below the age of 30 were at higher risk for aortic dilatation and aortic events
(aortic dissection or the need for prophylactic surgery) compared to women [9]. Further evi-
dence for male sex as a risk factor in humans with MFS was provided by data from the Dutch
Concor study, showing an increased incidence of aortic surgery at baseline (38.0 versus 19.4%)
and during follow-up (24.0 versus 15.1%) in men compared to women [10]. In surgical series,
on the other hand, male sex was not associated with a risk for recurrent interventions [11, 12].
However, it is not clear whether MFS women are protected against aortic disease or MFS men
are more prone to aortic disease.
Several retrospective studies in MFS patients indicated that pregnancy is considered as a
risk factor for developing aortic dissection [13–18]. A recent retrospective study by Roman
et al., using data from the GenTAC registry, reported an 8-fold increased risk of type A or B
aortic dissection in pregnant MFS women compared to never-pregnant MFS women [19].
This risk was especially increased during the immediate postpartum period. Of note, many of
the women experiencing pregnancy-related aortic dissection had not been diagnosed with
MFS prior to the event.
Until now, few prospective studies have been conducted [20–23]. These studies reported a
low incidence of aortic complications during pregnancy in women with a prior diagnosis of
MFS, an initial diameter of the aortic root 45 mm, and appropriate follow-up during preg-
nancy. During a total of 133 pregnancies, only 4 aortic dissections and 2 carotid artery dissec-
tions were reported [20–23]. Donnelly and colleagues noted that in the long-term, pregnancy
does increase the risk of aortic complications in MFS women [20]. In addition, this group and
others also reported increased aortic growth rate during pregnancy [20, 21].
The influence of sex and pregnancy on cardiovascular disease in MFS is becoming increas-
ingly studied. Preclinical animal research has, however, not followed suit. To date, no reports
have been published on the influence of sex or pregnancy on aortic disease in MFS mice. Both
in vivo and in vitro data obtained using mouse models could provide important insights into
disease mechanisms, which could lead to new options for clinical management and treatment
of patients.
To date, several Fbn1 mutant mouse models have been reported. These range in clinical
severity from the absence of any phenotypic features of MFS (Fbn1mgN/+ and Fbn1H1Δ/H1Δ) to
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mild MFS (Fbn1C1039G/+) and premature death due to aortic rupture (Fbn1mgN/mgN, Fbn1mgΔ/mgΔ,
Fbn1mgR/mgR, Fbn1GT-8/GT-8) [24–29]. Here, we studied the Fbn1GT-8/+ (GT-8/+) mouse model.
The mutant allele in this mouse model is truncated by the addition of an enhanced Green
Fluorescent Protein tag. Homozygous GT-8/GT-8 mice die during the early postnatal period,
similar to the complete null mouse (mgN/mgN) [24]. In heterozygosity, GT-8/+ mice have
a normal life span and present progressive fragmentation of the elastic lamellae of the aorta
as early as 2 months of age and fragmentation of microfibrils in skin, skeletal muscle and
tendon [25]. Gross ex vivo examination of the aorta indicated the presence of aortic aneu-
rysms in this mouse model. However, no systematic analyses of the aortic aneurysms were
performed.
In this study, the influence of sex and of pregnancy was investigated in MFS humans and
mice. Our results confirmed larger baseline aortic diameters in MFS men compared to MFS
women and increased aortic growth in pregnant MFS women compared to non-pregnant
MFS women. Similarly, male MFS mice have more severe aortic disease than female
mice and pregnancy adversely affects aortic disease. In addition, the female hormone 17β-
estradiol stimulates aortic smooth muscle cells to produce fibrillin-1 in vitro, providing a
hypothesis for a female protective effect against aortic disease due to increased production
of fibrillin-1.
Material and methods
Clinical studies
Aortic root dimensions were retrospectively recorded from a cohort of 20 women and 10 men
with MFS. Dimensions were measured with transthoracic echocardiography at the level of the
sinuses of Valsalva according to the guidelines (leading-to-leading edge, end-diastole). Aortic
root diameters were determined before pregnancy for the pregnant group or at an equivalent
time point for the non-pregnant and male group. These measurements are referred to as the
baseline measurements. In addition, measurements of the last echocardiography at follow-up
were used (mean follow-up time of 5,6 years (1,4–9,8 years)). Progression of aortic root dila-
tion was compared between 10 pregnant women (total of 13 pregnancies), 10 non-pregnant
women, and 10 men. Non-pregnant women and men were selected from our population of
MFS patients and were matched to the pregnant group for age.
The retrospective study in MFS patients was approved by the local ethical committee of the
Ghent University Hospital (permit number 2015–0411), and the procedures followed were in
accordance with institutional guidelines and conform to the principles outlined in the Declara-
tion of Helsinki. Participants included in the study gave written informed consent prior to
inclusion.
Mice
Details of the generation of GT-8/+ mice were described previously [25]. Male and female GT-
8/+ mice on a pure C57BL/6 background were used for this study. Polymerase chain reaction-
based genotyping was performed as previously described [25].
All experiments on mice were carried out in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
The protocols were approved by the Oregon Health & Science Institutional Animal Care and
Use Committee (Permit Number: ISO1405). All ultrasound analyses were performed under
isoflurane anesthesia, and all efforts were made to minimize suffering. Mice were sacrificed by
means of CO2 overdose (1.0L/min) and cervical dislocation.
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Cardiovascular ultrasound
Ultrasound imaging of the aorta of male and female wild-type and heterozygous GT-8/+ mice
was performed at the age of 8 and 12 months. Females were either nulliparous or allowed to
breed; number of pregnancies ranged from 1–4, average litter size was 6.4 pups). Number of
animals included at 8 months of age: n = 8 wild-type males; n = 11 GT-8/+ males; n = 13 nul-
liparous wild-type females; n = 5 multiparous wild-type females; n = 8 nulliparous GT-8/+
females; n = 19 multiparous GT-8/+ females. Number of animals included at 12 months of
age: n = 10 wild-type males; n = 12 GT-8/+ males; n = 13 nulliparous wild-type females; n = 2
multiparous wild-type females; n = 8 nulliparous GT-8/+ females: n = 14 multiparous GT-8/+
females. Ultrasound studies were performed under general anaesthesia (1–1.5% isoflurane
mixed with 0.5L/min 100% O2) using a dedicated ultrasound apparatus (Vevo 2100, Visualso-
nics) equipped with a high-frequency linear array transducer (MS 550D, frequency 22-
55MHz). Aortic dimensions were measured at the level of the sinuses of Valsalva, proximal
and distal ascending aorta, transverse arch and descending thoracic aorta. Ultrasound images
were analysed by one individual blinded to the genotype.
Light microscopy
Wild-type and GT-8/+ male and female mice were sacrificed at the age of 8 months (n = 7 M
wild-type; n = 6 M GT-8/+; n = 8 nulliparous F wild-type; n = 5 nulliparous F GT-8/+; n = 4
multiparous F wild-type; and n = 6 multiparous F GT-8/+), and between 12 and 16 months
(n = 3 M wild-type; n = 7 M GT-8/+; n = 7 nulliparous F wild-type; n = 11 nulliparous F GT-8/
+; n = 3 multiparous F wild-type; and n = 9 multiparous F GT-8/+) by means of CO2 overdose
(1.0L/min) and cervical dislocation. In situ aortae were flushed with phosphate buffered saline
(PBS) and dissected (including the aortic root up to the proximal part of the descending tho-
racic aorta). Aortas were fixed for a minimum of 12 hours at 4˚C in 1.5% glutaraldehyde/1.5%
formaldehyde with 0.05% tannic acid then rinsed in Dulbecco’s serum free media (41966–029,
Gibco™). Subsequently, the aortae were post-fixed for 24 hours in media buffered 1% osmium
tetroxide. Assisted by a Pelco Biowave Pro microwave processor, the tissues were dehydrated
in a graded series of ethanol (30%-100% at 100W for 1min/step), rinsed in propylene oxide (2x
at 100W for 1min/step), infiltrated in 1:1 and 1:3 propylene oxide:Spurr’s epoxy (250W for
15min/step) then in 3 changes of 100% Spurr’s epoxy (250W for 15min/step followed by over-
night at 4˚C) before embedding in fresh Spurr’s epoxy. 0.5 μm thick sections of the aortic root
were stained with toluidine blue and basic fuchsin and photographed on a Leica DMIRE2
inverted microscope fitted with a 10x objective, NA = 0.3. Images were collected using a QIma-
ging Micropublisher camera. The micrographs were analyzed to count fragmentation and
major breaks. Fragmentation was measured by counting the number of breaks in all lamellae
in full cross-sections of aortae. Breaks larger than what could be a plane-of-section artifact
were counted. Major breaks were defined as breaks that spanned more than 3 layers of elastic
lamellae. The number of fragments and large breaks per whole aorta section were counted by 2
separate individuals blinded to the genotype and averaged.
In vitro hormone assay and ELISA
Commercially available human aortic smooth muscle (CC-2571, Lonza) and fibroblast cells
(CRL 1537, American Type Culture Collection) were cultured in 24-well plates overnight. Sub-
sequently, the cells were treated with 1, 2, 4 or 8 nmol/L estrogen (17-β estradiol from Sigma,
E8875) or 100 ng/ml TGFβ-1 (240-B, R&D Systems) for 24 hours. Untreated cell cultures were
used as a control. Medium was collected and a modified sandwich ELISA was used to quanti-
tate secreted fibrillin-1 in cell culture medium as described previously [30]. Two antibody
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pairs consisting of a biotinylated (B) capture antibody and an alkaline phosphatase (AP)-con-
jugated detector antibody that recognize fibrillin-1 were used in this modified sandwich
ELISA, B15-AP201 and B15-AP78. B15 recognizes the proline-rich region; AP201 recognizes
the sixth calcium binding epidermal growth factor domain; and AP78 recognizes the second
calcium binding epidermal growth factor domain of fibrillin-1. Custom fibrillin-1 antibodies
have been described previously [31, 32]. In a first step, 96-well plates were coated for 18
hours at 4˚C with 0.3 μg/mL Pierce™ streptavidin (21135, ThermoFisher Scientific) in 0.05M
Na2CO3, 0.05M NaHCO3, pH 9.6. Subsequently, the plates were incubated for 1 hour at 25˚C
with 0.25 μg/ml biotinylated monoclonal antibody B15 in 50mM Tris, 150 mM NaCl, pH 7.4,
0.025% Tween20 (TBST) supplemented with 5% fetal bovine serum (FBS), followed by 20
hours incubation at 4˚C with untreated or treated culture media samples. Washes with TBST
were performed between each step to remove unbound material. All samples were run in
duplicate. Alkaline phosphatase-conjugated detector antibodies (AP201 and AP78 at 0.05 μg/
ml in TBST with 5% FBS) were used to complete the sandwich (1 hour incubation at 25˚C). A
standard curve was developed using a serial dilution of recombinant fibrillin-1 peptide rF11
(N-terminal half of fibrillin-1) in TBST with 10% FBS. To develop a colorimetric signal, 50 μl
of Invitrogen ELISA Amplification System (19589–019) substrate was added to each well for
15 minutes, followed by 50 μl of Invitrogen ELISA Amplification System amplifier for 7 min-
utes. The reaction was stopped by adding 50 μl of H2SO4. The colorimetric signal was read on
an Emax plate reader (Molecular Devices) at 490nm. The average absorbance of each sample
duplicate was computed and converted to μg/mL with an equation generated from the stan-
dard curve. A 4-parameter log logistic curve was fit to the standards. Graphs were generated
using GraphPad Prism software 5.04.
Statistics
Normal distribution of the human and mice ultrasound measurements was assessed by calcu-
lating the mean, median, skewness and kurtosis per dataset. For normal distributed ultrasound
values, as well as histological and ELISA data, one-way ANOVA followed by a post-hoc Bon-
ferroni, Tukey or Dunnett’s test was performed. For ultrasound values that were not normally
distributed, the Mann-Whitney-U or the Kruskal-Wallis test was applied. For nominal vari-
ables the Chi-square test was used. Results are shown as mean ± standard deviation, unless the
values were not normally distributed in which case median ± interquartile range are shown.
All values in mice are absolute measures, not corrected for length or weight. A p-value of
<0.05 was used to define statistical significance (two-sided). GraphPad Prism version 5.04 and
5.02 was used for the statistical analysis of the ultrasound data in mice, and the histological and
ELISA analyses, respectively. The SPSS version 23 was used for the statistical analysis of the
human ultrasound data. All graphs were generated with the GraphPad Prism version 5.04 or
5.02.
Results
Aortic root diameters in female and male Marfan patients
We first tested previously published findings of the influence of sex and pregnancy in MFS
patients using our Ghent cohort. We conducted a retrospective study of aortic dimensions
in an age-matched sample of 20 women with MFS (10 out of 20 women had been pregnant
with a total of 13 pregnancies) and 10 MFS men (Table 1). At baseline, aortic root diameters
were significantly higher in the men compared to the non-pregnant and pregnant women
(p = 0.040 and p = 0.002, respectively) (Fig 1A). Aortic diameters were higher in the non-
pregnant group compared to the pregnant group, although this difference was not significant
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(mean 36.9 mm versus 35.0 mm; p = 0.623) (Fig 1A). This finding possibly reflects the influ-
ence of aortic diameter in the decision to carry a pregnancy. No aortic dissection was observed
during pregnancy. Several years of follow-up (mean 5.6 years) revealed that the growth rate of
the aortic root was significantly higher in the pregnant group in comparison to the non-preg-
nant group (mean 0.64 mm/year versus 0.12 mm/year, p = 0.018) (Fig 1B). No significant dif-
ference in aortic growth rate was observed between the men and non-pregnant (p = 0.559) and
pregnant (p = 0.352) women. Maximal aortic diameter progression was observed in the preg-
nant group during the first period after pregnancy and stabilized thereafter (Fig 1A). Healthy
Table 1. Characteristics of the aortic root of MFS patients at baseline and after several years of follow-up.
men women p-value
non-pregnant pregnant
n 10 10 10
age (year) 26 (±10) 27 (±6) 27 (±3) 0.899
aortic root at baseline (mm) 40.8 (±3.52) 36.9 (±2.97) 35 (±3.40) 0.002a
Z-scores at baseline 3.33 (±1.41) 3.19 (±1.65) 1.32 (±0.76) 0.026
aortic root at follow-up (mm) 42.5 (±2.80) 37.9 (±3.10) 38.7 (±3.52) 0.007b
follow-up time (year) 5.00 (±2.75) 5.09 (±2.66) 6.63 (±3.74) 0.341
aortic root growth rate (mm/year) 0.36 (±0.35) 0.2 (±0.39) 0.64 (±0.42) 0.022c
Results are given as means with the standard deviation between brackets. Significant p-values (<0.05) are indicated in bold.
a Values are significantly different between men and non-pregnant and pregnant women (p = 0.040 and p = 0.002, respectively), but not between the non-
pregnant and pregnant women (p = 0.623).
b Values are also significantly different when pairwise comparing men and non-pregnant and pregnant women (p = 0.010 and p = 0.038, respectively).
c Significant difference only between non-pregnant and pregnant women (p = 0.018). No significant difference was observed between men and non-
pregnant (p = 0.559) or pregnant women (p = 0.352).
https://doi.org/10.1371/journal.pone.0181166.t001
Fig 1. Aortic root characteristics in MFS patients. A. At baseline, aortic root diameters are higher in men compared to
women. Non-pregnant women have higher aortic root diameters at baseline compared to pregnant women. After several
years of follow-up, aortic root diameters increase in men and pregnant women, but these barely increase in non-pregnant
women. Time interval between baseline and after pregnancy is 1.8 months, and between after pregnancy and follow-up is
5.5 years. * Values were only available for the pregnant women group at this time point. B. The growth rate of the aortic root,
measured at baseline and last follow-up, was significantly higher in the pregnant group in comparison to the non-pregnant
group. No significant difference in aortic growth rate was observed between the men and women. Results are shown as
means ± standard deviation, unless the values were not normally distributed in which case median ± interquartile range are
shown. ns: not significant; * p-value <0.05.
https://doi.org/10.1371/journal.pone.0181166.g001
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pregnant and non-pregnant women and men were not included in this study. Data on the
aorta during pregnancy in non-MFS women have been published elsewhere [33].
Aortic dimensions in male and female GT-8/+ mice
Ultrasound analyses of male heterozygous GT-8/+ mice at the age of 8 and 12 months demon-
strated larger aortic diameters at all levels compared to age-matched male wild-type littermates
(p<0.05 at the level of the aortic root at 8 months; and the aortic root, proximal and distal
ascending aorta and arch at 12 months) (Fig 2 and S1 Table). In fact, a trend towards larger
aortic diameters in male GT8/+ mice was observed as early as 1 month of age, with aortic
diameters significantly increased compared to wild-type male mice at later time points (S2
Table). Increased aortic root, ascending and aortic arch diameters were also observed in 8 and
12 months old multiparous GT-8/+ females compared to nulliparous GT-8/+ females (p<0.05
at the level of the aortic root, distal ascending aorta and arch at 8 months; and proximal and
distal ascending aorta and arch at 12 months) (Fig 2 and S1 Table). Nulliparous GT-8/+ females
differed only significantly from the wild-type nulliparous females at the level of the aortic root
(age 12 months). Aortic disease severity is similar between GT-8/+ males and GT-8/+ multipa-
rous females. However, aortic diameters at the level of the aortic root and distal ascending
aorta (8 months) and distal ascending aorta and arch (12 months) are significantly higher in
multiparous GT-8/+ females compared to GT-8/+ males (Fig 2 and S1 Table). In contrast, nul-
liparous GT-8/+ females are less severely affected than GT-8/+ males at both time points
(p<0.05 at the level of the distal ascending aorta at 8 months, and ascending and arch at 12
months). Mean aortic diameters are slightly higher in multiparous compared to nulliparous
wild-type females, however, these differences are not significant at 8 months of age (Fig 2 and
S1 Table). Due to the low n no statistics could be done for the 12 months time point. The num-
ber of pregnancies (range 1–4) and the time between the last pregnancy and the ultrasound
analysis (range 0.5–6 months) did not have an effect on aortic disease severity.
The natural history of this cohort of GT-8/+ heterozygous mice showed that none of the
mice died from aortic dissection/rupture. Two male GT-8/+ mice presented mild aortic valve
regurgitation associated with aortic dilatation (at 8 and 12 months of age respectively). Three
GT-8/+ multiparous female mice developed mild aortic valve regurgitation (1 at 8 months and
2 at 12 months of age) and two had significant aortic valve regurgitation with holodiastolic
flow reversal in the descending aorta at the age of 8 months. The mitral valve was not affected
in either of these two groups. None of the GT-8/+ nulliparous females or wild-type mice (both
males and females) developed valvular problems.
Sex- and pregnancy-related changes in the aortic wall of GT-8/+ mice
Heterozygous GT-8/+ mice showed progressive fragmentation of the elastic lamellae of the
aortic root, beginning at two months of age, increasing with age [25]. In the present study,
fragmentation of the elastic lamellae was quantitated. 8 months old male GT-8/+ mice showed
many more small breaks in the elastic lamellae compared to wild-type males (Fig 3). Similarly,
8 month old nulliparous and multiparous female GT-8/+ mice showed more severe fragmenta-
tion of the elastic lamellae of the aortic root, compared to wild-type females (Fig 3). No signifi-
cant difference in the numbers of small breaks (around 150 per cross-section) was seen
between male GT-8/+ mice and nulliparous or multiparous female GT-8/+ mice at this age
(Fig 3).
By 8 months of age, the aorta of GT-8/+ mice also showed the presence of major breaks,
defined as breaks spanning at least three consecutive layers of elastic lamellae. A marked differ-
ence was seen between nulliparous and multiparous GT-8/+ females when comparing the
Sex, pregnancy and aortic disease in MFS
PLOS ONE | https://doi.org/10.1371/journal.pone.0181166 July 14, 2017 7 / 16
Fig 2. Aortic dimensions of wild-type (+/+) and heterozygous GT-8/+ males (M) and nulliparous (np)
and multiparous (mp) females (F) at age 8 (panel A) and 12 months (panel B). Male and multiparous
female GT-8/+ mice show more severe aortic disease than wild-type mice and nulliparous GT-8/+ females at
both time points. Nulliparous GT-8/+ females differed only significantly from the nulliparous wild-type females
at the level of the aortic root at 12 months. In addition, nulliparous females have smaller aortic diameters than
the GT-8/+ males. Black lines represent the mean ± standard deviation. Non-significant differences are not
indicated in the figure. p-values: * <0.05, ** <0.005, *** <0.001, **** <0.0001.
https://doi.org/10.1371/journal.pone.0181166.g002
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number of major breaks in the aortic root. Multiparous GT-8/+ females had significantly
more major breaks in their aortic elastic lamellae compared to the nulliparous females. The
number of major breaks in multiparous GT-8/+ females was comparable to GT-8/+ males
at the age of 8 months (Fig 3). Similarly, older GT-8/+ mutant mice (ranging from 12–16
months) presented with more major breaks than the wild-type controls (ANOVA p = 0.0002)
(S2 Fig). Multiparous GT-8/+ females presented more major breaks than nulliparous GT-8/+
females and GT-8/+ males, with only the latter comparison being significantly different. Com-
pared to the 8 months old time point, male GT-8/+ mice show a similar number of major
breaks, but both nulliparous and multiparous female GT-8/+ mice are characterized by double
the amount of major breaks. Nulliparous GT-8/+ females thus catch up to the GT-8/+ males at
advanced age (S2 Fig). This increase in aortic root major breaks in nulliparous GT-8/+ females
is consistent with the significant increase in aortic root size found in 12 month old nulliparous
mutant females compared to wild-type (Fig 2).
Estrogen promotes fibrillin-1 production in vitro
Since women and female mice with MFS seem to have milder aortic disease than men and
male mice, we tested whether 17β-estradiol may be in part accountable for this protective
effect by influencing fibrillin-1 production. Fibrillin-1 production was significantly
increased upon administration of 17β-estradiol (4 or 8 nmol/L) to the medium of human
aortic smooth muscle cells (HASMC) compared to untreated HASMC or HASMC treated
Fig 3. Aortic root morphology in wild-type and heterozygous GT-8/+ mice at the age of 8 months. A. The aortic elastic
lamellae of GT-8/+ mice show clear fragmentation compared to the wild-type controls. Major breaks spanning at least 3 consecutive
layers of elastic lamellae can be found in male and multiparous female GT-8/+ mice. Scale bars = 100 μm. B. At the age of 8 months,
GT-8/+ male mice show significantly more fragmentation of the aortic elastic lamellae (left graph) and an increased number of major
breaks (right graph) compared to wild-type littermates. Similarly, nulliparous and multiparous female GT-8/+ mice both show
significantly more fragmentation of the aortic elastic lamellae compared to wild-type (left graph). The number of major breaks in the
aortic root of multiparous GT-8/+ female mice is, however, significantly higher than in nulliparous GT-8/+ female mice and
multiparous wild-type female mice (right graph). Each symbol represents a single animal. Means with 95% confidence intervals are
shown. F: female; M: male; np: nulliparous; mp: multiparous; p-values: * <0.05, ** <0.005, *** <0.001.
https://doi.org/10.1371/journal.pone.0181166.g003
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with low concentrations of 17β-estradiol (1 or 2 nmol/L) (Fig 4A). In comparison, Trans-
forming Growth Factor-β (TGFβ)-1, known to promote fibrillin-1 fibril formation by fibro-
blasts, did not induce HASMC to increase fibrillin-1 production. As a control, fibroblasts
were also treated with 17β-estradiol and TGFβ-1 (Fig 4B). While TGFβ-1 increased fibrillin-
1 synthesis and secretion by fibroblasts, 17β-estradiol did not. The magnitude of TGFβ-1
induction of fibrillin-1 production by fibroblasts was similar to the magnitude of fibrillin-1
production induced by 17β-estradiol in HASMC.
Discussion
To date, a limited number of clinical studies have reported on the impact of sex on aortic dis-
ease in MFS and related Heritable Thoracic Aortic Disease. It has, for example, been shown
that MFS men are at higher risk for increased aortic growth or aortic events (aortic dissection
and/or prophylactic surgery) compared to MFS women [9]-[10]. Also, Tran-Fadulu and col-
leagues observed sex disparity in multigenerational families with TAA caused by mutations in
the gene encoding the TGFβ receptor type 1 (TGFBR1) [34]–a finding that was recently con-
firmed in a larger international study [35]. In addition, there is a paucity of prospective data
that assess the impact of pregnancy on aortic disease in women with heritable thoracic aortic
disease. To date, pregnancy and aortic disease are still a widely debated issue. In contrast to the
few prospective studies in selected women under strict follow-up that have been published, ret-
rospective studies indicate an increased risk for aortic dissection during pregnancy [13–18].
Although this may be related to a publication bias towards the more severe cases, caution and
extra surveillance of these women during pregnancy is strongly advised. In addition to the
increased risk for dissection, there is concern that pregnancy triggers aortic growth and hence
can induce an increased risk for aortic events in the long term [20]. Large, multicenter pro-
spective studies are needed to clarify these issues. Our small retrospective study confirms the
absence of aortic events but increased aortic growth rate during pregnancy in women with
Fig 4. Fibrillin-1 production by (A) human aortic smooth muscle cells (HASMC) and (B) fibroblasts.
Cells were treated with 17β- estradiol and TGFβ-1 and compared to untreated control cells. Higher
concentrations of 17β-estradiol (4–8 nmol/L) compared to control (ctl) (0, 1 or 2 nmol/L 17β-estradiol)
promoted fibrillin-1 production by HASMC. In contrast, fibrillin-1 production by fibroblasts was stimulated by
TGFβ-1 but not by 17β-estradiol. Results shown were obtained using the antibody pair B15-AP201. Error bars
(standard deviation) are based on combining two separate experiments with HASMC and three separate
experiments with fibroblasts. In each experiment, samples were tested in duplicate. Significant p-values are
marked with an *.
https://doi.org/10.1371/journal.pone.0181166.g004
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MFS. Of note, these women are under strict follow up in accordance with the European guide-
lines applicable during pregnancy.
Even fewer studies report the impact of sex and pregnancy on thoracic aortic disease in
mouse models. This is a serious shortcoming, since sex-specific data in mice could potentially
be of great value to gain insights into clinical management and treatment of patients. The
only genetic TAA mouse model for which data on the impact of sex are available, is the Alk5iko
mouse. Selective deletion of Alk5 or Tgfbr1 in smooth muscle cells of adult mice results in tho-
racic aortic aneurysm and rupture in male mice, while female mice present only a subclinical
phenotype with mild fragmentation of the aortic elastic lamellae [36]. In the current study, we
provide evidence for a similar effect in GT-8/+ MFS mice. More severe aortic disease, mani-
festing as aneurysm and fragmentation of the elastic lamellae, is observed in male heterozygous
GT-8/+ mice when compared to female mice. Strikingly, this difference is only observed when
considering the nulliparous heterozygous GT-8/+ females. Multiparous heterozygous GT-8/+
female mice and male GT-8/+ mice have comparable aortic diameters and fragmentation of
the aortic elastic lamellae. None of the mice suffered from aortic dissection or rupture. More
multiparous GT-8/+ females did, however, present with aortic valve regurgitation compared
to the male GT-8/+ mice.
The presence of several major breaks across the elastic lamellae per cross-section of the aor-
tic root in male and multiparous female GT-8/+ mice suggests that severe fragmentation of the
elastic lamellae is associated with dilatation of the thoracic aorta and that more severe frag-
mentation is associated with larger aortic diameters. In humans with aortic aneurysms requir-
ing surgical replacement, pathological findings include severe fragmentation of the elastic
lamellae and cystic medial degeneration. In addition, circulating fragments of fibrillin-1 may
be biomarkers for aortic aneurysm and dissection [30]. Further study of the GT-8 Marfan
mouse model will allow the identification of molecular and cellular mechanisms that cause ini-
tial fragmentation as well as major breaks in the elastic lamellae.
Interestingly, aortic dilatation in GT-8/+ Marfan mice was not restricted to the aortic root,
but also included the ascending aorta and arch. This is in accordance with what has been
observed in most other MFS mouse models, including Fbn1mgN/mgN, Fbn1mgR/mgR, and
Fbn1C1039G/+ mice [24],[37],[38]. The involvement of a large part of the thoracic aorta in MFS
mice is different from the common aortic phenotype seen in MFS patients, in whom the aortic
dilatation is usually restricted to the level of the sinuses of Valsalva. Although far less common,
the descending thoracic and abdominal aorta of MFS patients can also be affected. Schoenhoff
and colleagues recently observed that the initial presentation in 8% of MFS patients was a
descending or thoraco-abdominal aortic aneurysm [11]. To date, it is not clear why mice con-
sistently develop aneurysms distal from the aortic root. Conceivably, hemodynamic differences
between bipedal and quadrupedal mammals may influence this phenotypical difference.
Previously, it has been hypothesized that sexual dimorphism in aneurysm models is influ-
enced by sex hormones. Several studies, however, documented contradictory results on the
role of (exogenous and endogenous) female and male sex hormones on aneurysmal disease.
Exposure of neonatal female mice to testosterone confers adult susceptibility to angiotensin II-
induced ascending and abdominal aortic aneurysms [39]. Furthermore, ovariectomy in female
Alk5iko mice doubled the aortic disease penetrance, suggesting that in this model sexual dimor-
phism is in part the result of the protective effect of endogenous ovary-derived sex hormones
[36]. The protective effect of 17β-estradiol has also been demonstrated in several elastase per-
fusion- and angiotensin-II infusion models of aortic aneurysms, as well as in genetic mouse
models [40–45]. It has been suggested that estrogen exerts its effect by influencing serum lipid
levels, inflammation and vessel wall homeostasis [42, 46, 47]. Previously, it has been shown
that female sex steroids can modulate arterial structure and function, since 17β-estradiol and
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progesterone can decrease collagen deposition and increase elastin deposition in human aortic
smooth muscle cell (HASMC) culture [48]. In addition, a combination of 17β-estradiol and
progesterone, increased fibrillin-1 deposition in the matrix of cultured human aortic SMCs
but only relative to testosterone, which significantly reduced fibrillin-1 expression compared
to controls [48]. Since it is known that high levels of female sex hormones are associated with
lower arterial stiffness, the authors suggested that female sex steroids influence this feature
through modulation of extracellular matrix homeostasis [48].
In our study, we tested whether 17β-estradiol promotes fibrillin-1 production in vitro. Few
compounds are known to increase fibrillin-1 synthesis and secretion. TGFβ was reported to
increase fibrillin-1 matrix deposition without increasing fibrillin-1 protein or RNA expression
[49]. We detected increased production of fibrillin-1 in response to TGFβ compared to con-
trols. 17β-estradiol, added in physiological concentrations, proved to be more potent than
TGFβ in the induction of fibrillin-1 by aortic smooth muscle cells. There are multiple possible
explanations for the less severe aortic disease found in nulliparous Marfan mice, but our obser-
vation that 17β-estradiol increased the production of fibrillin-1 by smooth muscle cells raised
the possibility that 17β-estradiol may improve aortic wall morphology and properties through
this mechanism, which could in turn ameliorate aortic disease. If true, this would open the
door to approaches aimed at increasing fibrillin-1 synthesis as possible treatments for aortic
aneurysm. Future research is definitely warranted.
We expect that, if protection of females is due to 17β-estradiol stimulation of fibrillin-1 pro-
duction, Fbn1C1039G/+ mice will show the same sex differences as GT-8/+ mice. In contrast, we
would predict that Fbn1mgR/mgR mice would not display sex differences in aortic disease, since
in this model Fbn1 expression is artificially repressed by the presence of the Neomycin cassette
(to 20% of wild-type) [27]. Thus, any factor increasing the expression or biosynthesis of fibril-
lin-1 would not be expected to show an effect in Fbn1mgR/mgR mice. This hypothesis should be
tested in future studies.
Despite the possibility that 17β-estradiol has a protective effect in female MFS mice, preg-
nant MFS mice showed more severe aortic disease than nulliparous female mice. Moreover,
the aortic phenotype of the multiparous GT-8/+ females was comparable to male MFS mice
and sometimes even worse. This may seem contradictory, since there is an increase in female
sex hormones, such as 17β-estradiol and progesterone, during pregnancy. Aortic root growth
(1.2 mm on average) occurs in healthy women during pregnancy, and the aortic root remains
enlarged for up to six weeks after delivery [33]. It is assumed that while these effects can be
largely disregarded in healthy women their impact on an underlying diseased aorta may have
severe consequences, as is reflected for example in an adverse immediate and long-term aortic
outcome in patients with Marfan syndrome [20, 21]. Pregnancy also affects the aorta in wild-
type mice to a minor extent. Multiparous wild-type females have slightly larger mean aortic
diameters than nulliparous wild-type females, but no significant differences are observed
between both groups at 8 months of age (no statistical analyses performed at 12 month time
point). This result supports the abovementioned assumption that an underlying aortopathy is
required for pregnancy to have a marked adverse effect on the aorta.
Multiple factors impact the aorta during pregnancy. In addition to the hormonal changes
inherent to pregnancy, which are meant to soften tissues in preparation for delivery and
increase tissue fragility, hemodynamic changes also occur. Increased cardiac output required
for adequate placental perfusion will result in increased wall shear stress in the aorta [50, 51].
Also, increased outflow resistance is present in the arterial tree in later stages of pregnancy,
due to compression of the abdominal aorta and iliac arteries by the uterus [50]. Possibly,
these hemodynamic effects undo the female sex hormone-related protective effect and
result in increased aneurysm formation. Indeed, in the Alk5iko mouse model it was shown
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that norepinephrine-induced hypertension breaks the female sex protective effect [50]. Future
studies in our MFS mouse model are warranted in order to unravel underlying disease mecha-
nisms and determine the influence of different factors, such as hormones and hemodynamics
on these mechanisms.
In conclusion, this is the first study providing evidence for an effect of sex and pregnancy
on both the dimensions and morphological characteristics of the aorta in MFS mice. In addi-
tion, we showed that 17β-estradiol promotes fibrillin-1 production in human aortic smooth
muscle cells and suggest that compounds that increase fibrillin-1 production in a Marfan dis-
eased aorta may have therapeutic potential for aortic aneurysms.
Supporting information
S1 Table. Aortic diameters in wild-type and GT-8/+ mice at 8 and 12 months of age. Mea-
surements are shown as mean ± standard deviation. P-values of the one-way ANOVA analyses
are listed.  The 12 months old wild-type multiparous female mice were excluded from the
ANOVA analyses because n was too low.
(XLSX)
S2 Table. Progressive aortic diameters in male wild-type and GT-8/+ mice. A detailed car-
diovascular ultrasound study at 1, 3, 6, 8 and 12 months in mutant and wild-type male mice
showed that male heterozygous GT8/+ mice are characterized by more extensive progressive
dilatation of the thoracic aorta compared to wild-type littermates. Although there was a trend
towards larger aortic diameters in GT8/+ mice as early as 1 month of age, aortic diameters
were only significantly increased compared to wild-type mice at later time points. The aortic
root diameter of GT-8/+ males is significantly increased compared to wild-types males from
the age of 3 months. The proximal ascending aorta diameter is significantly larger only in 12
months old GT-8/+ males compared to wild-types. Both the distal ascending aorta and arch
show significant differences in diameter from the age of 6 months. Results are given as
mean ± standard deviation. P-values were calculated using an unpaired student T-test. AR:
aortic root; PAscAo: proximal ascending aorta; DAscAo: distal ascending aorta; DescAo:
descending aorta.
(XLSX)
S1 Fig. Aortic root morphology of 8 months old wild-type and heterozygous GT-8/+ males
and females. Original full cross section micrographs of the images used in Fig 3A.
(TIF)
S2 Fig. Graphs of fragmentation of the aortic elastic lamellae in mice between 12–16
months of age. Increased numbers of major breaks in aortic elastic lamellae were seen in GT-
8/+ males and females compared to the wild-type controls (ANOVA p = 0.0002). The numbers
of major breaks in multiparous GT-8/+ females is higher than in nulliparous GT-8/+ females
and GT-8/+ males. Each symbol represents a single animal. Means with standard deviation are
shown; p-values:  <0.05,  <0.005,  <0.001. F: female; M: male; np: nulliparous; mp: mul-
tiparous.
(TIF)
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